| Not Yet Recruiting | A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants Basic Science | Phase 1 | 2026-03-15 |
| Active Not Recruiting | Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A Influenza a | Phase 3 | 2025-11-22 |
| Active Not Recruiting | Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A Influenza A | Phase 3 | 2025-11-08 |
| Not Yet Recruiting | A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 T2DM | Phase 3 | 2025-08-31 |
| Not Yet Recruiting | A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone T2DM | Phase 3 | 2025-08-31 |
| Recruiting | Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are Overweight Obesity | Phase 3 | 2025-06-15 |
| Active Not Recruiting | Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin Obesity | Phase 1 | 2025-04-14 |
| Completed | Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A Influenza a | Phase 2 | 2024-11-30 |
| Completed | A Study of RAY1225 in Participants With Impaired Kidney Function Kidney Impairment | Phase 1 | 2024-09-11 |
| Recruiting | A Study of RAY1225 in Participants With Impaired Liver Function Hepatic Impairment | Phase 1 | 2024-08-26 |
| Completed | A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes Healthy | Phase 1 | 2024-07-30 |
| Active Not Recruiting | A Study of RAY1225 in Participants With Type 2 Diabetes T2DM (Type 2 Diabetes Mellitus) | Phase 2 | 2024-02-26 |
| Recruiting | A Study of RAY1225 in Participants With Obesity Obesity | Phase 2 | 2024-02-21 |
| Completed | Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease Kidney Impairment | Phase 1 | 2024-01-15 |
| Completed | Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273 Bioequivalence | Phase 1 | 2023-11-23 |
| Completed | Pharmacokinetics of ZSP1273 in Elder Participants Elder | Phase 1 | 2023-10-11 |
| Completed | Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease Kidney Impairment | Phase 1 | 2023-09-26 |
| Completed | Mass Balance Study of [14C]RAY1216 in Healthy Adult Male Subjects in China Pharmacokinetics | Phase 1 | 2023-09-18 |
| Completed | Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic Impairment Hepatic Impairment | Phase 1 | 2023-09-14 |
| Completed | Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampi Drug Drug Interaction | Phase 1 | 2023-09-01 |
| Completed | Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants Elder | Phase 1 | 2023-08-24 |
| Completed | Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid Drug Drug Interaction | Phase 1 | 2023-07-10 |
| Completed | A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazol Drug Drug Interaction, Warfarin, Midazolam | Phase 1 | 2023-06-25 |
| Completed | Pharmacokinetics of ZSP1273 in Participants With Hepatic Impairment Hepatic Impairment, Pharmacokinetics | Phase 1 | 2023-06-15 |
| Active Not Recruiting | A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepa Nonalcoholic Steatohepatitis (NASH) | Phase 2 | 2023-06-03 |
| Completed | The Safety, Tolerability and Pharmacokinetic Study of RAY1225 Obese, Healthy | Phase 1 | 2023-05-18 |
| Completed | Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China Pharmacokinetics | Phase 1 | 2023-03-25 |
| Completed | Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19 Mild to Moderate COVID-19 | Phase 3 | 2022-11-12 |
| Completed | The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants COVID-19 (Coronavirus Disease 2019) | Phase 1 | 2022-05-20 |
| Completed | Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 / Phase 2 | 2021-10-21 |
| Completed | A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A Influenza A | Phase 3 | 2020-12-28 |
| Completed | Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir Drug-drug Interaction | Phase 1 | 2020-11-19 |
| Completed | Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH) Non-Alcoholic Steatohepatitis (NASH) | Phase 1 / Phase 2 | 2020-06-23 |
| Completed | Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A Influenza A | Phase 2 | 2019-12-07 |
| Completed | Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Nonalcoholic Steatohepatitis | Phase 1 | 2019-11-19 |